Vanguard Group
AEON icon

Vanguard Group’s AEON Biopharma AEON Stock Holding History

Vanguard Group’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$110K Buy
100,333
+1,765
+2% +$1.65K ﹤0.01% 4164
2025
Q3 		$79.7K Buy
+98,568
New +$76K ﹤0.01% 4251
2025
Q1 		– Sell
-10,404
Closed -$405K – 4281
2024
Q4 		$405K Sell
10,404
-31
-0.3% -$1.8K ﹤0.01% 3991
2024
Q3 		$789K Hold
10,435
– – ﹤0.01% 3840
2024
Q2 		$789K Sell
10,435
-107
-1% -$25.5K ﹤0.01% 3872
2024
Q1 		$8.8M Buy
10,542
+7,628
+262% +$5.52M ﹤0.01% 3032
2023
Q4 		$1.51M Buy
2,914
+224
+8% +$90K ﹤0.01% 3697
2023
Q3 		$1.08M Buy
+2,690
New +$1.23M ﹤0.01% 3802

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group's AEON Position: Q4 2025 in Review

Vanguard Group increased its AEON Biopharma (AEON) stake by 1.8% in Q4 2025, buying an estimated $1.65K and bringing the position to 100,333 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #4164.

Vanguard Group first reported a position in AEON in Q3 2023 and has held it in 8 quarters since. The position peaked at $8.8M in Q1 2024. 22 funds tracked by Wall St. Rank hold AEON as of Q4 2025.

  • Vanguard Group held 100,333 shares of AEON Biopharma worth $110K as of Q4 2025.
  • Vanguard Group bought 1,765 AEON Biopharma shares in Q4 2025, an estimated $1.65K.
  • AEON Biopharma made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4164 holding.
  • Vanguard Group first reported a position in AEON Biopharma in Q3 2023 and has held it in 8 quarters since.
  • Vanguard Group's AEON Biopharma position peaked at $8.8M in Q1 2024.
  • 22 funds tracked by Wall St. Rank held AEON Biopharma as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.